PHR Phreesia, Inc.
USHealthcareAs of 2026-07-10 11:56
Why PHR matters now
Phreesia, Inc. (PHR) is a US stock in Healthcare. The latest InvestLog snapshot shows $10.74 with -0.74% on the session and $663.9M in market capitalization; recent performance reads 1-month +2.29% and YTD -44.56%.
The latest financial table shown here is Q1 2027, with revenue of $130.9M, net income of $3.0M, and EPS of $0.05. Investors can compare that operating picture with valuation signals such as P/E unavailable and FCF yield 12.7%.
The latest indexable market news headline is "Deadline Soon: Phreesia Inc. (PHR) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit" from Business Wire.
Additional event context on this page matters because analyst consensus is Hold with a median target of $12.00; recent insider activity includes Hui Yvonne filing F-InKind; recent congressional disclosure data includes Josh Gottheimer Sale. These signals are research inputs, not a recommendation.
Valuation
P/E (TTM)
—
PEG
—
P/B
1.59
P/S
1.17
EV/EBITDA
14.09
DCF Value
$50.52
FCF Yield
12.7%
Div Yield
0.0%
Margins & Returns
Gross Margin
65.8%
Operating Margin
0.7%
Net Margin
1.9%
ROE
2.8%
ROA
1.4%
ROIC
-6.2%
Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2027 | $130.9M | $3.0M | $0.05 |
| Q4 2026 | $127.1M | $1.3M | $0.02 |
| FY 2026 | $480.6M | $2.3M | $0.04 |
| Q3 2026 | $120.3M | $4.3M | $0.07 |
Analyst Ratings
Consensus
Hold
Target (Consensus)
$13.57
Target (Median)
$12.00
Target Range
$9.00 - $22.00
Trading Activity
Insider Trades
Congress Trades
Related Stocks
Latest News
Company Info
Sector
Healthcare
Industry
Medical - Healthcare Information Services
Country
US
Exchange
—
Beta
0.88
Phreesia, Inc. offers a comprehensive, cloud-based software-as-a-service (SaaS) and payment platform specifically designed for the healthcare industry in the United States and Canada. Its flagship Phreesia Platform streamlines the patient intake process and facilitates integrated patient payment processing. The platform is accessible via multiple modalities, including Phreesia Mobile (a patient-facing mobile application), Phreesia Dashboard (a web-based portal for healthcare clients), self-service tablets known as PhreesiaPads, and on-site Arrivals Kiosks. The Phreesia Platform integrates a suite of specialized modules: An automated patient self-registration system. A revenue cycle management solution providing insurance verification, point-of-sale payment applications, and cost estimation tools. Access solutions for online appointment scheduling, reminders, and referral tracking. A life sciences solution delivering targeted, clinically relevant marketing content to patients. Additionally, a clinical support solution gathers clinical intake and patient-reported outcome (PRO) data across approximately 25 specialties, and enables healthcare clients to communicate with patients via surveys, announcements, text and email messaging, and health campaigns. Dedicated COVID-19 support modules assist with vaccine delivery management, identifying vaccine-hesitant individuals, screening for risk factors, facilitating contactless check-in, and managing telehealth visit intake. Phreesia serves a diverse clientele, including individual patients; single and multi-specialty practices, along with health systems; and pharmaceutical, medical device, and biotechnology firms. Established in 2005, the company maintains its headquarters in Raleigh, North Carolina.